Cubist Systematic Strategies’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $586K | Sell |
|
|||||
|
2025
Q2 | $7.67M | Sell |
|
|||||
|
2025
Q1 | $8.69M | Sell |
|
|||||
|
2024
Q4 | $11.6M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $10.8M | Buy |
|
|||||
|
2024
Q1 | $8.35M | Buy |
|
|||||
|
2023
Q4 | $12.1M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $2.73M | Sell |
|
|||||
|
2023
Q1 | $4.97M | Buy |
|
|||||
|
2022
Q4 | $173K | Sell |
|
|||||
|
2022
Q3 | $1.68M | Buy |
|
|||||
|
2022
Q2 | $393K | Sell |
|
|||||
|
2022
Q1 | $3.31M | Buy |
|
|||||
|
2021
Q4 | $1.05M | Sell |
|
|||||
|
2021
Q3 | $2.21M | Buy |
|
|||||
|
2021
Q2 | $1.9M | Buy |
|
|||||
|
2021
Q1 | $1.15M | Sell |
|
|||||
|
2020
Q4 | $5.38M | Buy |
|
|||||
|
2020
Q3 | $937K | Sell |
|
|||||
|
2020
Q2 | $12.9M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $1.51M | Sell |
|
|||||
|
2019
Q3 | $3.5M | Buy |
|
|||||
|
2019
Q2 | $194K | Sell |
|
|||||
|
2019
Q1 | $3.2M | Buy |
|
|||||
|
2018
Q4 | $87K | Sell |
|
|||||
|
2018
Q3 | $580K | Sell |
|
|||||
|
2018
Q2 | $453K | Buy |
|
|||||
|
2018
Q1 | $237K | Buy |
|
|||||
|
2017
Q4 | $156K | Sell |
|
|||||
|
2017
Q3 | $361K | Buy |
|
|||||
|
2017
Q2 | $74K | Sell |
|
|||||
|
2017
Q1 | $264K | Buy |
|
|||||
|
2016
Q4 | $192K | Buy |
|
|||||
|
2016
Q3 | $75K | Sell |
|
|||||
|
2016
Q2 | $563K | Buy |
|
|||||
|
2016
Q1 | $174K | Sell |
|
|||||
|
2015
Q4 | $2.02M | Sell |
|
|||||
|
2015
Q3 | $2.91M | Buy |
|
|||||
|
2015
Q2 | $2.05M | Buy |
|
|||||
|
2015
Q1 | $10K | Sell |
|
|||||
|
2014
Q4 | $53K | Sell |
|
|||||
|
2014
Q3 | $152K | Buy |
|
|||||
|
2014
Q2 | $111K | Buy |
|